Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan
NCT01464411
·
clinicaltrials.gov ↗
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Myelogenous Leukemia, Chronic, Chronic Phase
Sponsor
Kanto CML Study Group